« Back to Record
Citation APA

Bonnefoi, H., Biganzoli, L., Cufer, T., Mauriac, L., Hamilton, A., Schaefer, P., & Piccart-Gebhart, M. (2001). An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer. Breast cancer research and treatment, 70(1), 55-63.


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55270

Bonnefoi, H., Biganzoli, L., Cufer, T., Mauriac, L., Hamilton, A., Schaefer, P., & Piccart-Gebhart, M. (2001). An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer. Breast cancer research and treatment, 70(1), 55-63.